| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |